Literature DB >> 1550409

IgA antibody response to klebsiella in ankylosing spondylitis measured by immunoblotting.

F Shodjai-Moradi1, A Ebringer, I Abuljadayel.   

Abstract

IgA antibodies to Klebsiella pneumoniae var oxytoca and Proteus mirabilis were measured in 66 patients with ankylosing spondylitis (AS) and 31 with rheumatoid arthritis (RA) and in 51 healthy control subjects, using an immunoblotting technique. The number of antigenic bands to klebsiella on nitrocellulose membrane was higher in 28 patients with active AS than in 38 patients with inactive AS, 31 patients with RA, and 51 healthy control subjects; comparatively smaller increases were found against proteus. In two patients with AS the synovial fluid and the corresponding serum sample showed an identical antibody pattern. Increases in IgA antibodies to klebsiella in patients with AS confirm previous studies using other techniques.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550409      PMCID: PMC1005664          DOI: 10.1136/ard.51.2.233

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.

Authors:  D H Kono; M Ogasawara; R B Effros; M S Park; R L Waldord; D T Yu
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

4.  Fecal carriage of various Klebsiella and Enterobacter species in patients with active ankylosing spondylitis.

Authors:  T Hunter; G K Harding; R E Kaprove; M L Schroeder
Journal:  Arthritis Rheum       Date:  1981-01

5.  Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia.

Authors:  C G van Bohemen; F C Grumet; H C Zanen
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

Review 6.  The relationship between Klebsiella infection and ankylosing spondylitis.

Authors:  A Ebringer
Journal:  Baillieres Clin Rheumatol       Date:  1989-08

Review 7.  Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.

Authors:  A Ebringer; N L Cox; I Abuljadayel; M Ghuloom; S Khalafpour; T Ptaszynska; F Shodjai-Moradi; C Wilson
Journal:  Br J Rheumatol       Date:  1988

8.  C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; D Cawdell; M Ishii; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.

Authors:  A Trull; A Ebringer; G Panayi; R Ebringer; D C James
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; R Ebringer; G S Panayi; D Colthorpe; D C James; A Ebringer
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  13 in total

1.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

2.  Ig A antibodies to klebsiella in ankylosing spondylitis.

Authors:  O Ardiçoğlu; M B Atay; H Ataoğlu; N Etiz; H Ozenci
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

3.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Risk factors for urolithiasis in patients with ankylosing spondylitis: a prospective case-control study.

Authors:  Emel Gönüllü; N Şule Yaşar Bilge; Döndü U Cansu; Müge Bekmez; Ahmet Musmul; Nevbahar Akçar; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Urolithiasis       Date:  2016-08-19       Impact factor: 3.436

Review 5.  Urolithiasis as an extraarticular manifestation of ankylosing spondylitis.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; John A Sayer
Journal:  Rheumatol Int       Date:  2017-08-18       Impact factor: 2.631

6.  First report of septic arthritis caused by Klebsiella oxytoca.

Authors:  Armelle Ménard; Jérome Harambat; Sabine Pereyre; Jean-Roger Pontailler; Francis Mégraud; Olivier Richer
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

7.  Spondylarthropathy and selective IgA deficiency.

Authors:  S H Sprenkels; A Linssen; T E Feltkamp
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

8.  IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis.

Authors:  S H Sprenkels; E Van Kregten; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

9.  IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis.

Authors:  S H Sprenkels; J Uksila; R Vainionpää; P Toivanen; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

10.  Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.

Authors:  H Sahly; J Kekow; R Podschun; M Schaff; W L Gross; U Ullmann
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.